iPhone 12's market performance exceeded expectations in China as the new Apple smartphone series reportedly sold 18 million units before the end of 2020. This follows an earlier claim that the Cupertino, California-based tech giant is looking to increase iPhone shipments this year.
iPhone 12 sales reached 18 million units in China before 2020 ended
The announcement of the iPhone 12 happened a month later than usual, but it did not seem to affect how it performed in the market, at least in China. DigiTimes reported, per details from local media outlets, that Apple's newest smartphones have covered more than 20% of China's market share for the fourth quarter of 2020.
MacRumors pointed out that this shows how much influence the iPhone 12 series had on China's smartphone market. Before its announcement last October, more than 90% of the market share was distributed among the biggest Chinese smartphone makers, including Huawei, Xiaomi, Oppo, and Vivo. After Apple gained momentum in Q4 2020, that figured reportedly went down to 78%.
The favorable response iPhone 12 has seen could be attributed to Apple's overall upgrades to the smartphone series. Aside from a drastic change, the company also started its 5G adoption in this series, with all four devices in the lineup supporting the fastest mobile network available. All iPhone 12 models also shipped with OLED displays, while the Pro variants exclusively feature LiDAR scanner.
iPhones are expected to perform even better in 2021 as Apple was reportedly planning to ship up to 96 million units in the first half of the year. The overall iPhone shipment is anticipated to reach up to 230 million throughout the year.
iPhone 12's MagSafe affects pacemakers and other medical devices, study finds
Another notable new feature on all iPhone 12 models is the added support for MagSafe accessories allowing magnetic wallets and wireless chargers to work with the latest smartphones. However, this could have an unfavorable effect on certain users, especially those who have medical devices.
MacMagazine shared a study published in the Heart Rhythm Journal where a Medtronic pacemaker was deactivated when an iPhone 12 was held near the medical device. It is unclear yet if this should be a cause for concern, but Apple has previously addressed this matter in a safety information document.
"Though all iPhone 12 models contain more magnets than prior iPhone models, they're not expected to pose a greater risk of magnetic interference to medical devices than prior iPhone models," Apple advised. "Consult your physician and medical device manufacturer for information specific to your medical device and whether you need to maintain a safe distance of separation between your medical device and iPhone."


Quantum Systems Projects Revenue Surge as It Eyes IPO or Private Sale
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts
Apple Appoints Amar Subramanya as New Vice President of AI Amid Push to Accelerate Innovation
Nexperia Urges China Division to Resume Chip Production as Supply Risks Mount
Apple Leads Singles’ Day Smartphone Sales as iPhone 17 Demand Surges
Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature
ByteDance Unveils New AI Voice Assistant for ZTE Smartphones
Trump Administration to Secure Equity Stake in Pat Gelsinger’s XLight Startup
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp
Australia Releases New National AI Plan, Opts for Existing Laws to Manage Risks
Baidu Cuts Jobs as AI Competition and Ad Revenue Slump Intensify
Coupang Apologizes After Massive Data Breach Affecting 33.7 Million Users
Microchip Technology Boosts Q3 Outlook on Strong Bookings Momentum
YouTube Agrees to Follow Australia’s New Under-16 Social Media Ban
Apple Alerts EU Regulators That Apple Ads and Maps Meet DMA Gatekeeper Thresholds
Intel Boosts Malaysia Operations with Additional RM860 Million Investment
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment 



